Literature DB >> 22016347

A rare cause of hypertestosteronemia in a 68-year-old patient: a Leydig cell tumor due to a somatic GNAS (guanine nucleotide-binding protein, alpha-stimulating activity polypeptide 1)-activating mutation.

Rossella Libé1, Amato Fratticci, Najiba Lahlou, François R Jornayvaz, Frédérique Tissier, Estelle Louiset, Jean Guibourdenche, Annick Vieillefond, Marc Zerbib, Jérôme Bertherat.   

Abstract

Leydig cell tumors of the testis are the most common type of non-germ cell testicular tumors. In adult patients, gynecomastia, oligozoospermia, erectile dysfunction, and other signs of feminization can be present, whereas testosterone levels are frequently in the normal range or slightly reduced. We describe a patient with a history of impaired sexual function, as well as progressive enlargement of the left testis, without gynecomastia. Hormonal evaluation demonstrated very high testosterone, estrogen, and pan-alpha-inhibin levels. Magnetic resonance imaging revealed the presence of left testicular hypertrophy without evidence of testicular mass. After left orchiectomy, histologic examination confirmed the diagnosis of Leydig cell tumor, and steroid hormone levels normalized. A heterozygous missense somatic gsp mutation (R201C) was found in tumoral tissue, whereas no mutation was found in the surrounding normal tissue or in leukocyte DNA. This case provides evidence that somatic activating gsp mutation in Leydig cells may result in tumor development, leading to overexpression of the inhibin alpha subunit and hyperactivity of the testosterone biosynthetic pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22016347     DOI: 10.2164/jandrol.111.013441

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  5 in total

Review 1.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

2.  Adult height in pubertal boys with short stature treated with GH/letrozole: a hospital record-based retrospective study.

Authors:  Yaping Ma; Ruofan Jia; Bingyang Xia; Bin Tang; Zhuangjian Xu
Journal:  BMC Pediatr       Date:  2022-06-28       Impact factor: 2.567

3.  Leydig cell tumors of the testis: a case report.

Authors:  Ancuta Augustina Gheorghisan-Galateanu
Journal:  BMC Res Notes       Date:  2014-09-18

4.  Management of testicular Leydig cell tumor: A case report.

Authors:  Jianguo Zhu; Yun Luan; Haige Li
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

5.  The curious case of Gαs gain-of-function in neoplasia.

Authors:  Giulio Innamorati; Thomas M Wilkie; Havish S Kantheti; Maria Teresa Valenti; Luca Dalle Carbonare; Luca Giacomello; Marco Parenti; Davide Melisi; Claudio Bassi
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.